Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Open in API
Filings indexed 1,330 across all filing types
Latest filing 2020-05-04 Interim / Quarterly Rep…
Country DK Denmark
Listing CO AMBU

About Ambu

https://www.ambu.com

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for Q2 2019/20' and contains comprehensive financial statements, including income statements, balance sheets, cash flow statements, and management's review for the specified period. It provides detailed financial data and analysis rather than just an announcement or certification. Therefore, it is classified as an Interim/Quarterly Report. Q2 2020
2020-05-04 English
Ambu A/S: Interim report for Q2 2019/20 and for the period 1 October 2019 to 31 March 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for Q2 2019/20 and for the period 1 October 2019 to 31 March 2020' and contains detailed financial data including income statement, balance sheet, cash flows, key financial ratios, and management's review for the quarter and half-year periods. It discusses organic growth, EBIT margins, sales performance by region, and outlook guidance. The length is substantial (15,000 characters), and it includes comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarter and half-year). There is also mention of a conference call related to the report. This matches the definition of an Interim / Quarterly Report (IR). It is not a mere announcement or a certification, but a full financial report with substantive data and management commentary. Q2 2020
2020-05-04 English
Earnings Release 2020
Earnings Release Classification · 99% confidence The document title explicitly states 'Interim report for Q2 2019/20 and for the period 1 October 2019 to 31 March 2020'. This content details comprehensive financial results (revenue, EBIT, margins) for a period shorter than a full year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). Although it mentions a conference call, the primary content is the financial report itself, not just an announcement of the report's availability (which would be RPA/RNS). The length (5975 chars) also suggests the full report content is present, not just a brief announcement. H1 2020
2020-05-04 English
Earnings Release 2020
Earnings Release Classification · 100% confidence The document is a pre-announcement of financial results for Q2 2019/20, detailing organic revenue growth (24%), sales figures (313,000 endoscopes), and an upgrade to the full-year revenue guidance. It explicitly mentions the period (Q2) and provides key financial highlights before the official results announcement date (May 5, 2020). This structure—a summary of period performance and guidance adjustment released ahead of the full report—is characteristic of an Earnings Release (ER). It is not the comprehensive Interim Report (IR) itself, nor is it a transcript (CT) or a full Annual Report (10-K). Q2 2020
2020-04-06 English
Ambu A/S: Ambu reports revenue growth for Q2 and raises the revenue guidance for the year
Earnings Release Classification · 95% confidence The document is a 'Company announcement' (no. 8 2019/20) from Ambu, which provides a pre-announcement of Q2 financial results, including organic revenue growth figures and updated full-year guidance. It explicitly states that the full half-year results will be announced on a later date (5 May 2020). Because this is an initial announcement of financial highlights and guidance updates rather than the full interim report itself, it falls under the 'Earnings Release' category. Q2 2020
2020-04-06 English
Ambu A/S: Ambu’s production exempt from Malaysian movement control order
Regulatory Filings Classification · 95% confidence The document is a short company announcement (Company announcement no. 8 2019/20) regarding an operational update (exemption from a movement control order in Malaysia). It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate regulatory announcement, it falls under the RNS category.
2020-03-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.